However, patients in the low NRI group were more likely to be older, have more advanced tumor stage, and have lower performance status and lower levels of β2-MG, CRP, and HGB and less likely to have undergone transplantation than those in the high NRI group; the differences were statistically significant. This evidence concerns the gene CRP and neoplasm.